Cancer Vaccines (Conference News)

Allogeneic Vaccines May Be Viable Alternative to Autologous Vaccines

Published in Vaccine Weekly, November 24th, 1997

Success in animal models suggests that allogeneic cell cancer vaccines may be an effective alternative to autologous cell cancer vaccines.

The use of autologous cell cancer vaccines in clinical practice is limited by the invasive nature of harvesting cells, as well as the difficulty and expense of culturing and processing these cells. Justina Kayaga, representing colleagues from the St. George's Hospital Medical School, the Kings College School of Medicine and Dentistry, and the Royal Marsden Hospital, United Kingdom, presented results from animal studies using an alternative allogenic melanoma cell vaccine at the 3rd European Conference on Gene Therapy of Cancer, held...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1997-11-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry